The company’s master lease matures on April 30, 2026, but Genesis last month indicated it would exercise a five-year extension option. Genesis holdings are still largely concentrated in the ...
BURLINGAME, Calif.--(BUSINESS WIRE)--Genesis Therapeutics, a company pioneering generative and predictive artificial intelligence (AI) technologies to develop breakthrough therapeutics for underserved ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback